Mechanism and prevention of preterm birth.
Fuchs
A R
AR
Fuchs
F
F
D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000627:therapeutic use; D015237:Dinoprost / Q000031:analogs & derivatives*; D000431:Ethanol / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D010121:Oxytocin / Q000037:antagonists & inhibitors / Q000097:blood; D011247:Pregnancy; D011374:Progesterone / Q000502:physiology; D011460:Prostaglandins F / Q000097:blood; D012312:Ritodrine / Q000627:therapeutic use; D014590:Uterine Contraction / Q000187:drug effects
D000318:Adrenergic beta-Agonists; D000893:Anti-Inflammatory Agents; D002121:Calcium Channel Blockers; D011460:Prostaglandins F; C026528:15-ketoprostaglandin F2alpha; D000431:Ethanol; D011374:Progesterone; D010121:Oxytocin; D015237:Dinoprost; D012312:Ritodrine